시장보고서
상품코드
2138685

핸드헬드 미생물 에어 샘플러 시장 보고서 : 동향, 예측 및 경쟁 분석(-2035년)

Handheld Microbial Air Sampler Market Report: Trends, Forecast and Competitive Analysis to 2035

발행일: | 리서치사: 구분자 Lucintel | 페이지 정보: 영문 150 Pages | 배송안내 : 3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF, Excel & 1 Year Online Access (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,850 금액 안내 화살표 ₩ 6,565,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF & Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,700 금액 안내 화살표 ₩ 9,070,000
PDF, Excel & 1 Year Online Access (Corporate License) help
PDF & Excel 보고서를 동일 기업 내 동일 국가의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,850 금액 안내 화살표 ₩ 11,981,000
PDF, Excel & 1 Year Online Access (Global License) help
PDF & Excel 보고서를 동일 기업(완전 자회사 포함)의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 13,538,000
※ 부가세 별도
한글목차
영문목차

휴대용 미생물 에어 샘플러 시장

전 세계 휴대용 미생물 에어 샘플러 시장의 미래는 제약, 식품 및 음료 및 과학 실험실 각 시장의 기회로 인해 밝은 전망을 보이고 있습니다. 전 세계 휴대용 미생물 에어 샘플러 시장은 2027년 9,260만 달러에서 2035년에는 약 1억 4,540만 달러에 달할 것으로 예상되며, 2027-2035년까지 연평균 성장률(CAGR)은 5.8%를 기록할 전망입니다. 이 시장의 주요 성장 동인은 공기질 모니터링에 대한 수요 증가와 공기 전파성 질환에 대한 의식의 향상입니다.

  • Lucintel의 예측에 따르면 기종별로는 검출 정밀도와 시료 채취 속도가 뛰어난 2개의 시료 채취 헤드를 갖춘 기종이 예측 기간 중 높은 성장률을 보일 것으로 전망됩니다.
  • 용도별로는 제조 공정에서 미생물 증식 시의 오염 관리 요건이 엄격해지고 있으며, 제약 분야가 예측 기간 중 가장 높은 성장률을 보일 것으로 전망됩니다.
  • 지역별로는 아시아태평양(APAC) 지역의 제약 및 바이오기술 제조 확대에 힘입어, 예측 기간 중 해당 지역에서 가장 높은 성장이 예상됩니다.

휴대용 미생물 에어 샘플러 시장의 새로운 동향

휴대용 미생물 에어 샘플러 시장은 정기적인 규정 준수 시험에서 위험 기반의 실시간 환경 모니터링으로 진화하고 있습니다. 2025-2027년에 제약 업계의 역량 강화, 오염에 대한 더 엄격한 기준 설정, 그리고 커넥티드 기기의 통합으로 인해 구매 수요가 재편될 것입니다. Lucintel은 모든 생산 거점에서 감사에 대응할 수 있는 유효하고 신뢰할 수 있는 문서를 확보하면서, 동시에 시료 채취 시간을 단축할 수 있는 휴대용 시스템에 대한 수요가 증가할 것으로 예측하고 있습니다.

  • 지속가능성: 2025년 이후, 최종사용자들은 재사용 가능한 샘플링 헤드와 저전력 펌프를 요구하고 있으며, 제약 기업은 스코프 3 목표를 제시하고 있습니다. 일회용 부품을 줄인 시스템을 도입함으로써 일상 업무에서 발생하는 일회용 부품 폐기량을 20-30% 절감할 수 있습니다. 환경 보고가 부품 공급업체까지 확대되고 운영 비용에 대한 관심이 높아짐에 따라 이는 구매 동향에 영향을 미칠 것으로 보입니다.
  • 디지털 제조: 2025-2027년에 무선 기기,바코드 기술, 클라우드 컴퓨팅의 통합을 통해 구현되는 시스템이 종이를 많이 사용하는 공정을 대체하여, 데이터 전사와 문서화를 모두 대폭(50%) 줄일 수 있게 됨에 따라 미생물 공기 샘플링 장치의 구매는 더욱 증가할 것입니다.
  • 자동화: 2026년에는 고부가가치의 무균 제품을 보호하기 위해 자동화된 환경 모니터링이 수탁제조의 일부가 될 것입니다. 그러나 자동 센서로 보호할 수 없는 제품 설치 장소에서는 수동식 미생물 에어 샘플러가 계속해서 필요할 것입니다. 가이드 샘플링과 자동 유량 제어를 결합한 기법은 인력 부족이나 샘플링 시스템의 복잡화라는 과제 속에서도 일관된 샘플링을 유지하는 데 도움이 되는 자동화의 한 예입니다.
  • 기능성 제품: 2025년까지 고객은 흡입 기능만 갖춘 가장 단순한 모델이 아닌, 미생물 회수 기능, 사용자가 설정 가능한 용량, 신속한 상태 확인 기능을 갖춘 모델을 기대하게 될 것입니다. 그 결과, 가까운 미래에 표준화된 방법을 사용하여 시설 내에서 보다 용이하게 검증할 수 있는 100리터나 1,000리터 용량의 모델이 컨솔리데이터들에게 선호될 것입니다.
  • 지역별 공급망의 다양화: 2025년에 북미, 인도, 유럽에서 발표될 새로운 무균 제조 프로젝트로 인해 현재의 공급업체를 넘어선 공급망의 다양화가 진행될 것입니다. 또한 향후 3-5년 사이에 듀얼 소싱 및 현지 서비스 제공의 필요성도 대두될 것입니다.

제품 수요는 무균 제조, 병원 감염 관리 및 규제 대상인 실험실 업무에 계속해서 집중될 전망입니다. 구매자는 제품의 휴대성이 아닌 데이터 무결성, 회수율, 서비스 대응 및 총비용의 관점에서 샘플러를 비교 검토하게 될 것입니다. 검증이 완료된 하드웨어와 통합 소프트웨어를 갖춘 포괄적인 솔루션을 제공할 수 있는 벤더가 시장을 장악할 것으로 예상되는 반면, 저가 제품을 취급하는 벤더는 제품 공급에 있으며, 더 큰 어려움에 직면하게 될 것입니다.

휴대용 미생물 에어 샘플러 시장의 최근 동향

휴대용 미생물 에어 샘플러 시장은 단일 기기에서 연결형 환경 모니터링 시스템으로 전환되고 있습니다. 제약사가 오염 관리에 더욱 주의를 기울이고, 병원이 신속한 검증 절차를 요구함에 따라 이러한 추세는 2025-2027년까지 지속될 전망입니다. Lucintel에 따르면 디지털 품질관리 시스템을 지원할 수 있는 휴대용 시료 채취 장치에 대한 수요가 가장 높은 것으로 나타났습니다.

  • 연결형 데이터 시스템: 살토리아스(Sartorius)사는 2025년 3월, 디지털 바이오프로세스 연결 기능 개발을 시작했습니다. 그 결과, 감사에 적합한 결과를 내보낼 수 있는 기기에 대한 수요가 증가하고 있습니다. 향후 3-5년 동안 소프트웨어 통합은 규정 준수 시스템을 갖춘 시스템과 저비용 휴대용 기기를 차별화하는 요소가 될 것입니다.
  • 무균 제조에 대한 투자: 전 세계 제약 기업은 2025년 1월에 발표된 바이오젠의 20억 달러 투자를 포함해 무균 제조에 대한 투자를 지속하고 있습니다. 새로운 클린룸에서는 빈번하고 문서화된 공기 모니터링이 필요하며, 이는 샘플러 구매 및 도입 대수 증가를 촉진하고 있습니다.
  • 미생물 검출의 신속화: 액티브 에어 샘플러와 결합된 신속 미생물 검사법은 기존 방법이 수 시간에서 수일이 소요되던 것에 비해 24시간 이내에 결과를 제공하는 것을 목표로 하고 있습니다. 각 제조사가 배치 출시 결정부터 재고의 시장 출시까지 걸리는 시간을 단축하려는 가운데, 이는 시장에 영향을 미칠 것으로 보입니다.
  • 병원내 감염 관리 도입: 2025년, 의료 제공자들은 특히 수술실이나 면역 결핍 환자 치료실과 같은 고위험구역에 대한 감시를 강화했습니다. 제약 공장 이외의 분야에서 사용이 확대됨에 따라 시장은 성장하겠지만, 검증 및 직원 교육에 드는 비용이 높기 때문에 구매는 제한적일 것으로 보입니다.
  • 지역내 제조 거점 확대: 2025년 인도의 제약 부문 투자액은 10억 달러를 넘어섰습니다. 이에 따라 현지 수요가 증가함에 따라 교정 서비스와 소모품, 그리고 강력한 지역 커버리지를 포함하는 환경 모니터링 장비 분야에서 지역 간 경쟁이 격화될 것입니다.

향후 5년간 구매 우선순위로는 경쟁력 있는 가격에 더해, 검증된 데이터 확보와 신속한 서비스 대응이 중시될 것입니다. 규정 준수 관리 기능과 컴팩트한 크기를 겸비한 소프트웨어 및 하드웨어는 규제 대상 고객층에서 시장을 선도하는 입지를 확립할 것입니다. 당사 제품에 대한 수요는 여전히 지역에 따라 편차가 있을 것으로 보입니다. 그러나 시료 채취 활동이 매우 보편화됨에 따라 소모품 및 교정 서비스에 대한 수요로 인해 매출의 예측 가능성이 높아질 것으로 전망됩니다.

목차

제1장 개요

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 세계의 핸드헬드 미생물 에어 샘플러 시장 : 유형별

제5장 세계의 핸드헬드 미생물 에어 샘플러 시장 : 용도별

제6장 지역별 분석

제7장 북미의 핸드헬드 미생물 에어 샘플러 시장

제8장 유럽의 핸드헬드 미생물 에어 샘플러 시장

제9장 아시아태평양의 핸드헬드 미생물 에어 샘플러 시장

제10장 RoW의 핸드헬드 미생물 에어 샘플러 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 전체에서 주요 기업의 기업 개요

제14장 부록

KSA 26.10.07

Handheld Microbial Air Sampler Market

The future of the global handheld microbial air sampler market looks promising with opportunities in the pharmaceutical, food & beverage, and scientific laboratory markets. The global handheld microbial air sampler market is expected to reach an estimated $145.4 million by 2035 from $92.6 million in 2027 with a CAGR of 5.8% from 2027 to 2035. The major drivers for this market are the increasing demand for air quality monitoring and the growing awareness of airborne diseases.

  • Lucintel forecasts that, within the type category, two sampling heads is expected to witness higher growth over the forecast period due to better detection accuracy and sampling speeds.
  • Within the application category, pharmaceutical is expected to witness the highest growth over the forecast period due to tighter contamination control requirements during microbial growth in manufacturing.
  • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increasing pharmaceutical and biotech manufacturing in the region.

Emerging Trends in Handheld Microbial Air Sampler Market

The handheld microbial air sampler market is evolving from periodic compliance testing to real-time risk based environmental monitoring. Between 2025 and 2027, pharmaceutical capacity building, instituting more stringent limits on contamination, and integration of connected devices will reshape purchasing needs. Lucintel expects trending demand to be for portable systems for reducing the time for sampling while ensuring that valid, reliable documentations are available for an audit at all production locations.

  • Sustainability: In 2025 and onwards, end users are demanding reusable sampling heads and lower power pumps, and pharmaceutical companies are citing Scope 3 goals, systems that utilize lower disposables can achieve 20-30% EOL reductions of disposables in routine procedures. This will affect purchasing as environmental reporting reaches component suppliers, and the focus on operational costs widens.
  • Digital Manufacturing: Between 2025 and 2027, purchase of microbial air samplers will further increase as systems achievable through the integration of wireless devices, barcode technology and cloud computing will replace processes that are paper intensive and enable significant decreases (50%) in both data transcription and documentation.
  • Automation: In 2026, automated environmental monitoring will become a part of contract manufacturing for the protection of high value, sterile product. However, manual microbial air samplers will continue to be a necessity for product locations that cannot be protected by automated sensors. Guide sampling, in combination with auto flow control, is one example of automation that will help sustain consistent samplings amidst challenges of workforce shortage and increasing sampler system complexity.
  • Functional Products: By 2025, customers expect models with microbial collection, user-programmable volume, and rapid status, rather than the simplest version with aspiration. Consequently, in the near future, models with volumes such as 100 liters and 1,000 liters, which can be more easily validated in facilities with their standardized methods, will be preferred by consolidators.
  • Regional Supply Chain Diversification: The new sterile manufacturing projects announced in North America, India, and Europe in 2025 will create supply chain diversification beyond current suppliers. It will also establish the need for dual sourcing and local service within the next 3 to 5 years.

The demand for the products will remain focused on sterile manufacturing, hospital infection control, and regulated laboratory work. Buyers will compare samplers on data integrity, recovery, service response, and overall cost, rather than on the products being portable. It is expected that vendors who can offer a complete solution with validated hardware and integrated software will dominate the market, while vendors with low cost products will encounter more difficulties when supplying their products.

Recent Developments in the Handheld Microbial Air Sampler Market

The market for handheld microbial air samplers is shifting from standalone devices to connected environmental monitoring systems. This will remain the case through 2025 to 2027, as pharmaceutical manufacturers pay increased attention to their contamination control and as hospitals require a quick verification process. According to Lucintel, the strongest demand is for portable samplers that can be used to support digital quality systems.

  • Connected Data Systems: Sartorius began developing digital bioprocess connectivity in March 2025. As a result, there is a greater demand for devices that export results suitable for audit. During the next 3 to 5 years, software integration will differentiate compliant systems from low-cost portable devices.
  • Aseptic Manufacturing Investment: Global pharmaceutical companies continue to invest in aseptic manufacturing, including the $2 billion Biogen investment that was announced in January 2025. New cleanrooms require frequent, documented air monitoring, which supports the purchase of samplers and the growth of the sampler fleet.
  • Faster Microbial Detection: Rapid microbiological methods paired with active air samplers are aimed at providing results within 24 hours, rather than the hours or days traditional methods require. This will impact the market as manufacturers seek to decrease the time between batch release decisions and the exposure of their inventory.
  • Hospital Infection-control Adoption: Healthcare providers increased surveillance of high-risk areas during 2025, particularly operating rooms and immunocompromised-care units. Wider use outside pharmaceutical manufacturing plants will broaden the market, although purchasing will be limited due to the high cost of validation and staff training.
  • Regional Manufacturing Expansion: The investment in India's pharmaceutical sector during 2025 is over $1 billion. This increases local demand and throws regional competition into environmental monitoring equipment that includes calibration services and consumables along with strong regional coverage.

Purchasing preferences will prioritize recovery validated data and service response within the next 5 years along with competitive pricing. Software and hardware that combine managing compliance and compact size will secure market leading positions in regulated accounts. Much of the demand for our products will continue to be uneven across regions. However, the sampling activities will become so commonplace that we can expect greater predictability in sales because of the demand for consumables and calibration services.

Strategic Growth Opportunities in the Handheld Microbial Air Sampler Market

As pharmaceutical industry regulations evolve to control contamination and as the manufacture of biologics expands, the handheld microbial air sampler market is expected to grow. Lucintel anticipates the growth of portable environmental monitoring beyond traditional clean room applications to be a viable possibility. Between 2024 and 2026, the need for more flexible, portable testing and the increasing emphasis on faster decision-making and more decentralized aseptic processing are expected to drive market growth.

  • Biopharmaceutical Manufacturing: The sampling of air within a cell and gene therapy suites will become more important because, especially with mycotoxins, negative impacts from contamination can be significant. In January 2025, the FDA's manufacturing database showed more than 100 approved biological products and reinforced the need for portable air sampling devices to support operations at specialized manufacturing facilities. The anticipated growth will influence the market as manufacturers build additional specialized facilities to produce Advanced Therapy Medicinal Products.
  • Food and Beverage Quality Control: Many food producers have started to place more emphasis on microbial testing that is done near the processing lines. In March 2025, the FDA reported more than 1,000 inspections of food-processing facilities that fall in the scope of their preventive-control program. Hand-held devices are expected to help reduce the time it takes to complete an investigation along with the auditing of suppliers. This should enhance the sales potential of these devices in large processing facilities.
  • Hospital Infection Control: Healthcare systems have untapped market potential for operative suites, isolation rooms, and safe compounding rooms. In February 2025, CDC guidelines still included environmental controls to help address infection prevention concerns. The market should grow in response to the demand for portable monitoring when construction, outbreaks, and intrusive controls are being addressed.
  • Geographic Expansion in Asia-Pacific: In Venezuela, increased local pharmaceutical investments are driving a need for compliant environmental monitoring infrastructure outside of more established western markets. As of October 2022, the Government of India reported a 30 billion USD projection for drug exports by 2025. Over the next five years, regional distributors and service partners may financially benefit from this drug manufacturing growth.
  • Connected Compliance Services: Buyers are achieving more efficient compliance by purchasing instruments with built-in audit trails and cloud reporting, as opposed to purchasing a standalone sampler with validation service contract. Implementation of EU GMP Annex 1, which requires a high level of data integrity, has been in effect for more than 2 years resulting in increased visibility to data integrity requirements. Vendors can increase revenue for their solutions that offer subscription licenses and services while reducing the need for documentation.

Procurement will favor suppliers that provide measurement accuracy with integration of workflow software. The strongest commercial opportunities will be the validated instruments with a local service and software offering which converts sampling data into inspection records. Vendors should implement this service first in regulated production, and then adapt simplified offerings for hospital and food production. While price competition increases, strong compliance service should maintain the profit margins and encourage repeat buying.

Handheld Microbial Air Sampler Market Drivers and Challenges

The growth of the handheld microbial air sampler market can be attributed to technology, the economy, regulation, and sustainability. There are growing needs in healthcare, pharmaceutical, food processing, and cleanroom segments. The market is driven by portable automation and greater accuracy in detection of contamination with greater emphasis on contamination control, whereas the market is restrained by cost, calibration needs, and a lack of standardization. Lucintel states that quality requirements are shifting.

The factors responsible for driving this market include:

  • Customer Requirements: There is a need for reliable airborne microbial monitoring within hospitals, pharmaceutical facilities, laboratories, and food processing to avoid contamination and maintain the quality of the product. The total market of the pharmaceutical industry was projected to reach $5 trillion by 2025. This need drives the replacement of manual sampling with handheld portable instruments to achieve fast and traceable results. In the next three to five years, the quality expectations will increase, and the manufacturing of biologics will continue to grow along with the expected needs for greater emphasis of infection control. The market will grow for handheld samplers that offer rapid sampling and easy use, provide data storage, and are designed for routine environmental monitoring.
  • Technology Advancements: Advances in battery technology, software, and wireless connectivity, along with improvements in airflow control and sampling technologies, provide more accuracy and usability in sampling systems. Brand new monitoring systems introduced in January 2026 included cloud-based reporting and audit trails, allowing users to accurately record sampled information and eliminate transcription errors during compliance inspections. These systems also provide automation for recording sampling data including sample volume, operator name, sampling time and location. Improved portability allows sampling systems to be utilized in production areas. In the next three to five years, artificial intelligence will allow handheld samplers to provide onsite trend analysis and prompt alerts to quality management systems. Laboratory information management systems integrations will also help driven sampler adoption in digital quality management systems.
  • Regulatory Support: Good manufacturing practice regulations combined with expectations for environmental monitoring provide justification for evaluating the sampling of airborne microorganisms in closed systems. There was a regulatory emphasis on data integrity and documented environmental monitoring in the 2025 version of major pharmaceutical markets inspection priorities. Regulations may not mandate one particular instrument type, but they do provide a need for trustworthy evidence that a facility is operating under acceptable conditions. Handheld samplers allow users to collect portable, repeatable and auditable records. There will be greater demand for validated systems with good calibration and data security in the next three to five years due to the increased focus on regulations for contamination prevention, maintaining sterile manufacturing and electronic documentation.
  • Sustainability: Manufacturers require monitoring equipment to eliminate waste and conserve energy and disposable material. Many health and pharmacy-related service providers have declared emissions reduction goals for 2030 (approximately 20% reduction from baseline for 2025) and need solutions focused on sustainability. An ideal solution includes a combination of reusable sampling heads, durable housings, replaceable batteries, media with optimized consumption to name a few considerations. All designs need to include the long-term cost consideration and view sustainability as an added benefit. During the next three to five years, environmental purchasing considerations will drive the need for sustainability within manufacturing. Supply chains will reshape to provide more sustainably designed products. Manufacturers will be expected to have products that are easier to repair, manufactured with more sustainable and durable packaging and longer battery life and software that minimizes sampling cycles.
  • Manufacturing Efficiency: Production facilities will require contamination tests that can be done quickly without long disruptions to the process. In 2025, many automated pharmaceutical and food manufacturing plants increased the adoption of digital quality systems, with some document time reduction as much as 30% in these systems. Handheld samplers aid this initiative with quick deployment, programmable sampling, bar code functionality, and rapid data transfer to the system. Contamination risks can be minimized with quicker monitoring and reduction of costly batch investigations. In the next three to five years, manufacturers will prioritize equipment that enhances worker productivity, simplifies system validation, and easily integrates quality, maintenance and production management systems.

The challenges facing this market include:

  • Cost of Acquisition and Ownership: An advanced microbial air sampler is a significant investment, beyond the cost of the device. This includes the investment for calibration, software, accessories, and validation. Portable units, with greater levels of automation and connectivity, were in the range of 3,000 to 15,000 USD in 2025. Due to the cost of ownership and the slow replacement of older models, smaller food processors and many smaller laboratories are likely to continue using basic models or outsource their testing. Suppliers have 3-5 years to create alternate lower cost solutions, leases, service contracts, and more modular systems to provide cost-effective customized microbial air samplers. Alternatively, many may decide to only sell into less price sensitive markets.
  • Complexity of Use: Sampling microbes involves many factors including air flow, sampling duration, culture media, sampling hygiene, and user skills. In 2026, common issues during quality audits included undocumented and/or uncalibrated systems in environmental monitoring programs. Improper user settings can lead to microbial levels exceeding action limits, resulting in unnecessary investigations and potentially allowing the process to remain out of control. The use of a microbial air sampler spans many sites, which can increase the total cost. To address these issues, systems should be built with automated checks, easier to use workflows and simplified calibration procedures. Better sampler usability and training systems will help ensure these systems remain consistent as their use expands beyond specialist laboratories.
  • Different Countries, Industries, and Facilities: As illustrated by the differences in reporting practices of international manufacturers in 2025, countries, industries, and facilities can have varying definitions of sampling locations, alert levels, the required sampling media, and the way in which methods are interpreted. Air samplers have the potential to collect viable microorganisms under certain culture conditions, causing some microorganisms to be either un-measurable or requiring prolonged incubation. These limitations can affect the consumer's confidence in the rapid test. Over the next 3-5 years, growth of the market will rely on the coordination of existing methods, greater validation of the methods, complementary rapid tests, and more clearly articulated instrument capabilities and correct test results.

Increased concern with contamination control, greater digital monitoring, regulatory compliance, sustainability goals, and greater operational efficiency will support the growing market. Greater market innovation will increase portability, connectivity, and reliability of data. Larger markets may provide new opportunities. High costs, complexity, calibration, and the lack of standards may constrain market growth. Strongest growth will be in the supplies that combine affordability, validation, automation, and sustainability in the next 3-5 years.

List of Handheld Microbial Air Sampler Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies handheld microbial air sampler market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the handheld microbial air sampler market companies profiled in this report include-

  • MBV
  • Sartorius
  • Particle Measuring Systems
  • VWR
  • SIBATA
  • LightHouse
  • BioMerieux
  • Bertin Technologies
  • Climet Instruments
  • Orum International

Handheld Microbial Air Sampler Market by Segment

The study includes a forecast for the global handheld microbial air sampler market by type, application, and region.

Handheld Microbial Air Sampler Market by Type [Value ($M) from 2019 to 2035]:

  • Single Sampling Head
  • Two Sampling Heads

Handheld Microbial Air Sampler Market by Application [Value ($M) from 2019 to 2035]:

  • Pharmaceutical
  • Food & Beverage
  • Scientific Laboratory
  • Others

Handheld Microbial Air Sampler Market by Region [Value ($M) from 2019 to 2035]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Handheld Microbial Air Sampler Market

The market for handheld microbial air samplers has grown due to the increase in drug production in key regions and higher expectations for contamination control. From now until 2027, regulators and manufacturers will focus on rapid, integrated environmental monitoring. Lucintel's new report indicates that these scenarios will create consistent demand for portable sampling systems.

  • United States: The FDA's focus on aseptic processing and the construction of new pharmaceutical plants by companies (e.g. Eli Lilly's contribution of $27 billion to constructing four new U.S. pharmaceutical manufacturing plants, February 2025) will create demand for handheld samplers in pharmaceutical and biologics plants over the next three to five years.
  • China: The National Medical Products Administration of China is implementing the revised pharmaceutical manufacturing and inspection laws while WuXi Biologics reported a 2024 capacity of more than 1.3 million liters. Larger domestic and export-focused manufacturing plants will require broad air monitoring and instrument standardization.
  • Germany: EU GMP Annex 1 is the benchmark, and Vetter has announced a €230 million expansion of its Ravensburg site, including aseptic capacity (June 2025). This project will also create demand for portable microbial air samplers for monitoring during qualification, validation, and batch operations.
  • India: The changes to Schedule M have prompted improvements to quality systems and the Serum Institute of India has committed to a ₹3,000 crore investment for vaccine manufacturing (January 2025). All new and renovated plants will demand more frequent documented environmental sampling to secure both domestic and export approvals.
  • Japan: The PMDA continues to apply international GMP expectations and Fujifilm has made a ¥30 billion investment to its bio-CDMO facility in Thousand Oaks, California, in January 2025, to strengthen its existing Japanese manufacturing operations. Continued biologics investments should further advance the use of modular sampling systems approved for use in an electronic records and validated cleanroom environment.

Features of the Global Handheld Microbial Air Sampler Market

  • Market Size Estimates: handheld microbial air sampler market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
  • Segmentation Analysis: handheld microbial air sampler market size by type, application, and region in terms of value ($B).
  • Regional Analysis: handheld microbial air sampler market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the handheld microbial air sampler market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the handheld microbial air sampler market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the handheld microbial air sampler market by type (single sampling head and two sampling heads), application (pharmaceutical, food & beverage, scientific laboratory, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Handheld Microbial Air Sampler Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Single Sampling Head: Trends and Forecast (2019-2035)
  • 4.4 Two Sampling Heads: Trends and Forecast (2019-2035)

5. Global Handheld Microbial Air Sampler Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Pharmaceutical: Trends and Forecast (2019-2035)
  • 5.4 Food & Beverage: Trends and Forecast (2019-2035)
  • 5.5 Scientific Laboratory: Trends and Forecast (2019-2035)
  • 5.6 Others: Trends and Forecast (2019-2035)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Handheld Microbial Air Sampler Market by Region

7. North American Handheld Microbial Air Sampler Market

  • 7.1 Overview
  • 7.2 North American Handheld Microbial Air Sampler Market by Type
  • 7.3 North American Handheld Microbial Air Sampler Market by Application
  • 7.4 United States Handheld Microbial Air Sampler Market
  • 7.5 Mexican Handheld Microbial Air Sampler Market
  • 7.6 Canadian Handheld Microbial Air Sampler Market

8. European Handheld Microbial Air Sampler Market

  • 8.1 Overview
  • 8.2 European Handheld Microbial Air Sampler Market by Type
  • 8.3 European Handheld Microbial Air Sampler Market by Application
  • 8.4 German Handheld Microbial Air Sampler Market
  • 8.5 French Handheld Microbial Air Sampler Market
  • 8.6 Spanish Handheld Microbial Air Sampler Market
  • 8.7 Italian Handheld Microbial Air Sampler Market
  • 8.8 United Kingdom Handheld Microbial Air Sampler Market

9. APAC Handheld Microbial Air Sampler Market

  • 9.1 Overview
  • 9.2 APAC Handheld Microbial Air Sampler Market by Type
  • 9.3 APAC Handheld Microbial Air Sampler Market by Application
  • 9.4 Japanese Handheld Microbial Air Sampler Market
  • 9.5 Indian Handheld Microbial Air Sampler Market
  • 9.6 Chinese Handheld Microbial Air Sampler Market
  • 9.7 South Korean Handheld Microbial Air Sampler Market
  • 9.8 Indonesian Handheld Microbial Air Sampler Market

10. ROW Handheld Microbial Air Sampler Market

  • 10.1 Overview
  • 10.2 ROW Handheld Microbial Air Sampler Market by Type
  • 10.3 ROW Handheld Microbial Air Sampler Market by Application
  • 10.4 Middle Eastern Handheld Microbial Air Sampler Market
  • 10.5 South American Handheld Microbial Air Sampler Market
  • 10.6 African Handheld Microbial Air Sampler Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Handheld Microbial Air Sampler Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 MBV
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Sartorius
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Particle Measuring Systems
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 VWR
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 SIBATA
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 LightHouse
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 BioMerieux
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Bertin Technologies
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Climet Instruments
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Orum International
    • Company Overview
    • Handheld Microbial Air Sampler Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기